The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel: Updated results including progression-free survival (PFS) and patient-reported outcomes (PROs) (TheraP ANZUP 1603).
 
Michael S Hofman
Consulting or Advisory Role - Endocyte; Janssen
Research Funding - Endocyte (Inst)
Travel, Accommodations, Expenses - Genzyme; Ipsen; Janssen
 
Louise Emmett
Honoraria - AstraZeneca; Janssen Oncology; Mundipharma
Consulting or Advisory Role - Noxopharm
Speakers' Bureau - Janssen Oncology; Janssen Oncology; Mundipharma
Research Funding - Novartis (Inst); Novartis (Inst); Noxopharm (Inst); Noxopharm (Inst)
 
Shahneen Kaur Sandhu
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck Serono (Inst)
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Endocyte/Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Amir Iravani
No Relationships to Disclose
 
Anthony M. Joshua
Consulting or Advisory Role - AstraZeneca (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Neoleukin Therapeutics (Inst); Novartis (Inst); Noxopharm (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Jeffrey C. Goh
Stock and Other Ownership Interests - Immutep
Honoraria - Ipsen
Consulting or Advisory Role - AstraZeneca; Tesaro
Speakers' Bureau - AstraZeneca; Ipsen; Janssen; Mundipharma; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca
 
David A. Pattison
Consulting or Advisory Role - Telix Pharmaceuticals
Travel, Accommodations, Expenses - Ipsen
 
Thean Hsiang Tan
Speakers' Bureau - Ipsen; Janssen Oncology
 
Ian D. Kirkwood
Stock and Other Ownership Interests - Alcidion; CSL Limited; ResMed; Sonic Healthcare
Research Funding - Provectus (Inst)
 
Siobhan Ng
Honoraria - Astellas Oncology; AstraZeneca; Ipsen; Janssen; Merck Sharp & Dohme; Mundipharma; Pfizer
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Ipsen; Janssen; Merck Sharp & Dohme; Mundipharma; Pfizer
 
Roslyn J. Francis
No Relationships to Disclose
 
Craig Gedye
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Novotech; Pfizer (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Astellas Pharma (Inst); Astellas Pharma (Inst); Merck Sharp & Dohme (Inst)
 
Natalie K. Rutherford
No Relationships to Disclose
 
Alison Yan Zhang
Honoraria - Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Mundipharma; Pfizer (Inst)
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Margaret Mary McJannett
No Relationships to Disclose
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - Medivation/Pfizer
 
John A. Violet
No Relationships to Disclose
 
Scott Williams
Consulting or Advisory Role - Amgen; Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Andrew James Martin
No Relationships to Disclose
 
Ian D. Davis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Ipsen (Inst); Janssen Oncology (Inst); Medivation (Inst); Movember Foundation (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.